Cancer care innovation: Atrium Health, Penn Medicine + more share barriers and opportunities in the evolving landscape

Wednesday, April 24th, 2024 | 12:00 PM - 1:00 PM CT 

While new technologies like molecular cancer testing are creating better treatment opportunities for patients, they also pose additional complexities in data, clinical guidelines, costs and access. 

In this interactive session, leaders from Atrium Health's (Charlotte, N.C.) Levine Cancer Institute, Penn Medicine's Princeton (N.J.) Medical Center, Sharp HealthCare (San Diego) and Alameda (Calif.) Health System's Highland Hospital will share current challenges they're facing as they serve increasing numbers of cancer patients while driving innovation.
You'll learn:
  • Current cancer trends + health systems' technology strategies
  • How organizations are navigating barriers and complexities, like increases in data, more available therapies and clinical trials, and costs/coverage
  • Outlooks on sustainability of the business of cancer care

Snehal Thakkar - headshot

Snehal Thakkar

Sr. Director of Medical Affairs, Exact Sciences Precision Oncology

Mellisa Wheeler - Sarah Simon-2

Mellisa Wheeler

Director Disparities & Outreach, Levine Cancer Institute

Kerri Celaya - Sarah Simon

Kerri Celaya

Director of Cancer Services, Penn Medicine Princeton Medical Center

Wendy Photo-1

Wendy Mbugua MSN, RN

Vice President of the Oncology Service Line, Sharp HealthCare

Kevin Knopf-1

Kevin Knopf MD, MPH

Division Chief of Hematology & Oncology, Highland Hospital of the Alameda Health System